NHOA: Q4 2022 Trading and Operational Update
"Q4 2022 just finished and the results achieved are once more impressive. At Group level 2022 Revenues reach €165 million, perfectly in line with the upward revised guidance and expectations to achieve
Stay updated with breaking news from Not Applicable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"Q4 2022 just finished and the results achieved are once more impressive. At Group level 2022 Revenues reach €165 million, perfectly in line with the upward revised guidance and expectations to achieve
DJ Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc The Vanguard Group, Inc. ( IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 30-Jan-2023 / 13:40 GMT/BST Dissemination
DJ Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc The Vanguard Group, Inc. ( IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 27-Jan-2023 / 13:06 GMT/BST Dissemination
DJ Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc The Vanguard Group, Inc. ( IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 24-Jan-2023 / 13:34 GMT/BST Dissemination
DJ Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc The Vanguard Group, Inc. ( IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 23-Jan-2023 / 13:26 GMT/BST Dissemination